Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug;88(4):807-14.
doi: 10.1111/j.1476-5381.1986.tb16253.x.

Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens

Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens

A G Blakeley et al. Br J Pharmacol. 1986 Aug.

Abstract

Excitatory junction potentials (e.j.ps) were recorded from mouse vas deferens and resolved into families of 'discrete events' (d.es) reflecting intermittent release of packets of transmitter from one or a few sites. Within families d.es vary in amplitude between a few preferred values unaffected by any treatments used in these experiments. As [Ca]o is raised from 1.1 to 4.0 mM there is a rise in d.e. amplitude due to an increase in the frequency of large events and a decrease in that of small. At all [Ca]o clonidine reduces d.e. amplitude by increasing failures and small events and decreasing large events. Yohimbine has opposite effects. Both drug effects are concentration-dependent in the range 5 X 10(-9) - 10(-6)M. As [Ca]o is raised from 1.1 to 4.0 mM, and therefore more natural agonist is released, clonidine becomes more effective at altering d.e. amplitude whereas yohimbine becomes less so. With very low frequency stimulation yohimbine elevates e.j.p. amplitude only if [Ca]o is below 1.6 mM. These results are not easily compatible with the notion that yohimbine breaks a 'negative feedback' control of transmitter release.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Rev. 1970 Sep;22(3):389-428 - PubMed
    1. Neuroscience. 1984 Sep;13(1):21-8 - PubMed
    1. Rev Physiol Biochem Pharmacol. 1977;77:1-124 - PubMed
    1. Br J Pharmacol. 1977 Aug;60(4):481-97 - PubMed
    1. Physiol Rev. 1977 Oct;57(4):659-728 - PubMed